Comment on the editorial by Turner et al. on assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by Zannad et al.

  • Kristina Dunder, Pieter A de Graeff, Eberhard Blind
  • European Heart Journal - Cardiovascular Pharmacotherapy, April 2017, Oxford University Press (OUP)
  • DOI: 10.1093/ehjcvp/pvx006

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1093/ehjcvp/pvx006